ESC - European Society of Cardiology
ESC - European Society of Cardiology
08/31/2024 | Press release | Distributed by Public on 08/31/2024 04:07
Transcatheter edge to edge repair is better than medical therapy alone in patients with heart failure and mitral regurgitation
Notes to editor
This press release accompanies both a presentation and an ESC press conference at ESC Congress 2024. It does not necessarily reflect the opinion of the European Society of Cardiology.
ESC Press Office
Tel: +33 (0)6 61 40 18 84
Email: [email protected]
The hashtag for ESC Congress 2024 is #ESCCongress
Follow us on X @ESCardioNews
Journalists are invited to become accredited and register here.
Check out the ESC Media and Embargo Policy.
Funding: The legal sponsor of the study was the University Medical Center Göttingen (Germany). Financial support for the trial was provided through an unrestricted grant from Abbott Laboratories to the University Medical Center Göttingen (Germany).
Disclosures: Stephan Anker reports grants and personal fees from Vifor and Abbott Vascular, and personal fees for consultancies, trial committee work and/or lectures from Actimed, AstraZeneca, Bayer, Bioventrix, Boehringer Ingelheim, Brahms, Cardiac Dimensions, Cardior, Cordio, CVRx, Cytokinetics, Edwards, Farraday Pharmaceuticals, GSK, HeartKinetics, Impulse Dynamics, Medtronic, Novartis, Novo Nordisk, Occlutech, Pfizer, Regeneron, Relaxera, Repairon, Scirent, Sensible Medical, Servier, Vectorious and V-Wave. He reports that he is the named co-inventor of two patent applications regarding MR-proANP (DE 102007010834 & DE 102007022367), but he does not benefit personally from the related issued patents.
References and notes
1'RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure' will be discussed during Hot Line 3 on Saturday 31 August in room London.
2Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307-2318.
3Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297-2306.
It is the world's largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in London and online - from 30 August to 2 September. Explore the scientific programme. More information is available from the ESC Press Office at [email protected].
About the European Society of Cardiology
The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.